Michelle Finegan

Director, Global Patient Advocacy at Respivant Sciences - San Diego, CA, US

Michelle Finegan's Colleagues at Respivant Sciences
Karissa Sanabria

Director Clinical Operations

Contact Karissa Sanabria

Michelle Finegan's Contact Details
HQ
N/A
Location
Encinitas,California,United States
Company
Respivant Sciences
Michelle Finegan's Company Details
Respivant Sciences logo, Respivant Sciences contact details

Respivant Sciences

San Diego, CA, US • 20 - 49 Employees
BioTech/Drugs

Respivant Sciences, a subsidiary of Roivant Sciences, is global, clinical-stage biopharmaceutical company dedicated to developing new therapies for patients with respiratory diseases.The company's lead candidate, RVT-1601, is currently being evaluated in the SCENIC study for people with idiopathic pulmonary fibrosis (IPF), a progressive lung disease characterized by scarring of the lung for unknown reasons, to assess the potential of a new inhaled therapy to significantly reduce cough and improve quality of life. RVT-1601 is an inhaled non-steroidal, anti-inflammatory drug delivered directly to the lungs via a hand-held, silent, electronic nebulizer. Learn more at https://www.respivant.com.

N/A
Details about Respivant Sciences
Frequently Asked Questions about Michelle Finegan
Michelle Finegan currently works for Respivant Sciences.
Michelle Finegan's role at Respivant Sciences is Director, Global Patient Advocacy.
Michelle Finegan's email address is ***@respivant.com. To view Michelle Finegan's full email address, please signup to ConnectPlex.
Michelle Finegan works in the Research industry.
Michelle Finegan's colleagues at Respivant Sciences are Karissa Sanabria and others.
Michelle Finegan's phone number is N/A
See more information about Michelle Finegan